Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19252,135,0.97 [0.82-1.13],0.6734671204049885
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",20084,154,1.02 [0.88-1.19],0.7452512223351455
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19875,1147,1.04 [0.98-1.10],0.1667167855668281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,20095,308,0.97 [0.87-1.07],0.5356497882145822
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19502,2839,1.02 [0.98-1.06],0.2748282872917162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19490,2863,1.00 [0.96-1.03],0.9462201151454468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19917,858,1.02 [0.95-1.08],0.6113389811325578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,20037,68,0.92 [0.73-1.15],0.4431934121818748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18243,892,1.00 [0.94-1.06],0.9908724747761438
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17589,980,1.00 [0.94-1.06],0.9999779435997276
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17415,205,0.98 [0.86-1.12],0.7804758932292171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14145,1864,0.98 [0.94-1.03],0.4572811253002515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17352,325,1.07 [0.97-1.18],0.1893082359528993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,20087,1028,1.02 [0.96-1.08],0.5700932111875141
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,20169,382,0.95 [0.86-1.04],0.2844785497858181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19449,721,1.04 [0.97-1.11],0.3179226256046884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,20105,988,0.99 [0.93-1.05],0.6513578498012015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,19215,156,1.02 [0.88-1.19],0.7653598198953604
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,20203,41,1.04 [0.78-1.38],0.8077441607154325
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19976,859,0.99 [0.93-1.06],0.8754250431332823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,20022,53,1.14 [0.89-1.47],0.2927301275889307
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,20142,99,1.03 [0.86-1.24],0.725149646132166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",20127,84,1.13 [0.93-1.38],0.23029111239741
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,19124,396,1.12 [1.03-1.23],0.0128147950143609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18961,233,0.99 [0.88-1.12],0.8884452622163366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,19128,69,0.96 [0.77-1.20],0.7459046654759156
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,20186,57,0.91 [0.71-1.15],0.4223403135536824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,20156,118,1.03 [0.87-1.22],0.7481759537193606
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,20083,45,1.10 [0.84-1.44],0.5031580723529171
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],20079,41,1.02 [0.76-1.36],0.9125740666614184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19941,297,1.02 [0.92-1.13],0.7457934817011478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,20143,41,1.06 [0.80-1.41],0.6778701837961816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,20109,49,1.02 [0.78-1.32],0.8880073817712565
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,20167,108,0.99 [0.83-1.19],0.9498973671964576
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19882,1370,0.97 [0.92-1.02],0.2363295901596236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,20202,27,0.98 [0.69-1.39],0.9112760025122082
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,20150,53,0.90 [0.70-1.16],0.4152799868239691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,20190,64,1.09 [0.87-1.37],0.4667882773609503
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,20180,384,0.95 [0.87-1.05],0.3168444909850182
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,20184,289,1.03 [0.93-1.15],0.582362305255105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",20091,62,1.12 [0.89-1.41],0.3450719781358203
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,20177,236,0.98 [0.87-1.11],0.7558724063964329
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,20139,360,0.91 [0.83-1.01],0.0686516601562476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,20094,614,0.99 [0.92-1.06],0.6947814477274474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,20168,466,0.98 [0.90-1.06],0.5815929455770665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15731,62,1.08 [0.86-1.36],0.5179226475548101
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15729,60,0.83 [0.65-1.05],0.1226955072101687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",20174,75,0.99 [0.80-1.22],0.8986777327342383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",20174,72,1.00 [0.80-1.24],0.9861474846383632
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,13475,302,1.04 [0.93-1.15],0.5040400293849819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lymphoid leukaemia,15726,57,1.11 [0.87-1.42],0.3971995653114708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15833,164,1.14 [0.99-1.31],0.0793952118856717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15910,241,1.01 [0.89-1.13],0.9315359629349638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15746,77,0.86 [0.69-1.06],0.1542159156256702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15783,114,1.03 [0.87-1.22],0.7452742010741736
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15793,124,0.98 [0.83-1.16],0.8158686258791514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15737,68,0.96 [0.77-1.20],0.7177455415487544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16839,1170,0.97 [0.92-1.03],0.3262336817967516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15796,127,0.90 [0.76-1.06],0.2024024272853109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15765,96,1.06 [0.88-1.28],0.522088404381494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15770,101,1.14 [0.95-1.37],0.1725195773560563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,20104,148,0.92 [0.79-1.07],0.2887833873193874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,20178,86,1.07 [0.88-1.30],0.5024841931720365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanoma in situ,15697,63,1.14 [0.90-1.44],0.2685890122978217
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15755,86,0.95 [0.78-1.16],0.6133038962765243
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15807,138,0.93 [0.79-1.08],0.336264474900107
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15864,195,0.99 [0.87-1.13],0.9337652337272402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15752,83,0.82 [0.67-1.00],0.0523691368257887
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,20093,122,1.03 [0.87-1.22],0.7102606656065545
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16677,1008,0.97 [0.92-1.03],0.3460366729772396
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16737,1068,0.99 [0.93-1.04],0.6254796536675544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19973,251,1.03 [0.92-1.16],0.5724045729904681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18787,66,1.06 [0.85-1.33],0.6059086907406201
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19778,56,1.08 [0.84-1.38],0.5484060946149105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19764,2267,1.00 [0.97-1.04],0.8411154803612714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,19183,52,1.28 [0.99-1.64],0.0555759247511856
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19852,41,0.64 [0.48-0.86],0.003342411407443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19915,1194,1.01 [0.96-1.07],0.6887875420728401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19913,1192,1.01 [0.96-1.06],0.7258264040935676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18799,78,0.86 [0.70-1.06],0.1506647206817135
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,20017,886,1.07 [1.00-1.14],0.0378711867759798
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19902,91,1.10 [0.91-1.33],0.3437997141646828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19784,62,0.87 [0.69-1.10],0.2489694599591574
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19778,56,1.16 [0.91-1.48],0.2335187710626638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,20063,252,0.76 [0.68-0.86],6.573416992311889e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,20122,40,0.85 [0.64-1.14],0.2756961845544031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",20016,205,0.74 [0.65-0.84],6.025832226930688e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,19191,60,0.79 [0.62-1.01],0.0631605764152294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14971,297,0.97 [0.87-1.08],0.6305444617171512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18465,132,1.13 [0.97-1.33],0.1261141426709098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18496,163,0.93 [0.80-1.07],0.3082463461581937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14725,51,1.20 [0.93-1.55],0.1652675771430348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,19070,53,0.94 [0.73-1.21],0.6541898350926649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18421,182,0.91 [0.79-1.04],0.1573044874273665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19814,479,0.98 [0.90-1.06],0.5709382634419864
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19535,200,0.92 [0.81-1.05],0.2207393868548999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19451,116,1.07 [0.90-1.26],0.4609517305209021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19956,939,1.07 [1.00-1.13],0.0377183617380403
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17334,907,1.05 [0.99-1.12],0.0907662641442218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14734,60,0.93 [0.73-1.18],0.5640555847647926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19497,36,1.06 [0.78-1.44],0.712112172105136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14894,220,1.03 [0.91-1.16],0.6684293120755368
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14733,59,1.03 [0.81-1.30],0.836563994615623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17925,3251,1.03 [1.00-1.07],0.0538180011985881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14828,154,0.85 [0.73-0.98],0.0300003346577962
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15136,462,0.98 [0.90-1.07],0.6193572606284179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,20154,227,1.03 [0.91-1.16],0.6254259638535693
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,20000,73,0.87 [0.70-1.08],0.203645018115229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14800,126,1.02 [0.87-1.20],0.819623842569839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14728,54,0.93 [0.73-1.20],0.5843440222777696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,20053,592,1.00 [0.93-1.08],0.9468244768666244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14924,250,1.09 [0.97-1.23],0.1387222859889649
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14964,290,0.86 [0.77-0.96],0.0072957930670523
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15277,603,1.10 [1.02-1.18],0.0131629866324202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14786,112,0.92 [0.77-1.10],0.3563286613713473
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19994,67,0.87 [0.70-1.09],0.2383193835330358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15153,479,1.07 [0.98-1.16],0.1285074489449449
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15011,337,1.04 [0.94-1.15],0.4660547125016807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18288,49,1.05 [0.81-1.36],0.7078248230425902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,19043,4369,1.02 [0.99-1.04],0.2904306046287003
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19473,12,0.98 [0.58-1.67],0.946136025674482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19482,21,1.05 [0.71-1.57],0.7998924983709019
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,20061,1493,0.97 [0.93-1.02],0.2688037530197109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",20057,1488,0.97 [0.93-1.02],0.2812907864050995
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19473,12,1.39 [0.82-2.35],0.2196170941759116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19981,679,1.04 [0.97-1.12],0.2741947686208599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16011,1337,1.01 [0.96-1.06],0.6713040574537931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,20194,196,0.84 [0.74-0.97],0.0131189030803809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19421,86,0.81 [0.66-0.99],0.0391249160686614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19363,61,1.12 [0.89-1.41],0.3396749283240012
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19374,72,1.36 [1.10-1.68],0.0049439533155586
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14731,57,1.04 [0.81-1.33],0.762374043690371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17851,143,1.03 [0.88-1.20],0.7104297614120205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2135,102,1.01 [0.84-1.22],0.8816610485943581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2271,266,0.95 [0.85-1.07],0.3994630290028302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17790,82,1.08 [0.88-1.33],0.4402919937675461
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2091,58,0.97 [0.76-1.25],0.8330473680932128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19560,1852,1.02 [0.97-1.06],0.4280029388347319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19610,275,0.88 [0.79-0.98],0.0257050268358166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18435,196,0.95 [0.84-1.09],0.4728616621415428
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15306,632,0.99 [0.92-1.07],0.7946563472437163
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",20095,204,0.86 [0.75-0.97],0.0185842562895261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),19191,228,0.84 [0.74-0.95],0.0051659569127961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17786,1249,0.97 [0.92-1.03],0.3051102578751965
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19289,326,0.87 [0.78-0.96],0.0066423553163712
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,19031,68,1.00 [0.80-1.25],0.9890741210406588
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",19154,191,1.03 [0.91-1.18],0.6203674896102227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11822,1909,0.95 [0.92-1.00],0.0335408051377069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,AV-block,16309,500,0.97 [0.89-1.06],0.4916116926044739
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",20143,429,1.01 [0.92-1.10],0.862741583790894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,10124,211,1.05 [0.92-1.19],0.477122212339361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15981,172,0.86 [0.75-0.99],0.0386740632910195
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15900,91,0.86 [0.71-1.04],0.116429306794144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,20203,49,0.97 [0.74-1.27],0.8150326841741717
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,16928,1119,0.98 [0.93-1.04],0.5086003378720286
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18714,2198,1.00 [0.96-1.04],0.9251220102510458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17099,6613,0.99 [0.97-1.02],0.6170676364312293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,19165,225,0.86 [0.76-0.97],0.0147415218229678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,15881,72,0.87 [0.70-1.08],0.2096899095979207
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19938,1104,1.01 [0.96-1.07],0.644145271424953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,18107,5751,1.01 [0.98-1.03],0.4884012892467124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18111,5755,1.01 [0.98-1.03],0.5259564777611954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",20007,98,0.78 [0.64-0.94],0.008428057319877
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12527,171,1.05 [0.91-1.21],0.4961436103109748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12457,101,0.98 [0.82-1.18],0.841999294521787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,20079,992,1.06 [1.00-1.12],0.056335947851823
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19312,98,0.82 [0.68-0.99],0.0354366507080487
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18839,2302,1.00 [0.96-1.04],0.9256660581286794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19860,558,1.02 [0.94-1.10],0.598700650122652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,16151,342,1.05 [0.95-1.16],0.3739941226712008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19614,894,1.01 [0.95-1.07],0.8116401870001148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17310,773,1.03 [0.96-1.10],0.3781110175115284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",20068,188,1.03 [0.90-1.18],0.6394311137834425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",20159,312,1.03 [0.93-1.14],0.6208531666400134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18994,54,0.81 [0.63-1.05],0.1148799031323548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,19041,78,1.08 [0.88-1.33],0.4660783888668534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,16215,406,1.02 [0.93-1.12],0.6293183075410023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,19073,110,0.99 [0.83-1.18],0.9379819891371044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,19189,226,0.94 [0.83-1.06],0.3196788458601794
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15964,155,1.00 [0.86-1.16],0.9809979346223324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,19016,76,0.88 [0.71-1.09],0.2549191973987661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18979,39,1.05 [0.78-1.40],0.7676555395333095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18889,73,1.10 [0.88-1.36],0.3978363267516348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,19025,85,0.95 [0.77-1.16],0.5894699872341672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16842,1033,0.99 [0.93-1.05],0.7340236940764789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,19142,55,0.83 [0.64-1.07],0.1469372759598023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19430,467,1.03 [0.95-1.12],0.4474680518192547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19664,320,1.08 [0.97-1.20],0.1519321492747012
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19367,551,1.00 [0.93-1.08],0.9645015976853816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10220,307,0.93 [0.84-1.03],0.1839897504852204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19349,429,1.05 [0.96-1.15],0.2756569095791678
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19232,292,0.88 [0.79-0.98],0.0163801319258612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19757,413,0.96 [0.87-1.05],0.3432773251257042
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,20149,588,1.02 [0.94-1.10],0.700936222781448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16201,392,0.95 [0.87-1.04],0.2870079388948598
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19663,319,1.07 [0.97-1.19],0.1761454407375286
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,19001,185,1.00 [0.87-1.15],0.9934865760601816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19846,632,1.00 [0.93-1.08],0.980117336289751
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19834,656,1.00 [0.93-1.07],0.992583139105982
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19295,38,0.90 [0.66-1.21],0.4751538183871771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,19059,97,0.82 [0.68-0.99],0.0397155292182323
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19498,196,1.05 [0.92-1.20],0.4575158458894908
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18983,263,0.99 [0.89-1.11],0.8890858698523293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,19262,322,0.94 [0.85-1.05],0.269100974594644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18979,61,0.87 [0.69-1.11],0.2646908951813968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,20000,643,0.92 [0.85-0.99],0.0222081050146027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",20030,421,0.97 [0.88-1.06],0.4383999102391592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17411,817,1.07 [1.00-1.14],0.0526810894335069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,19625,3031,1.01 [0.98-1.05],0.4039176336327614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19977,487,0.98 [0.90-1.06],0.6090862048212448
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17567,973,1.05 [0.99-1.12],0.0770270310667734
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16655,61,1.12 [0.89-1.41],0.3437237494987051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,19638,1294,1.02 [0.97-1.07],0.4920069132292328
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18165,1571,1.01 [0.97-1.06],0.6142385992828299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,19816,123,0.91 [0.77-1.07],0.2550585254166803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,20203,249,0.94 [0.84-1.06],0.301735530023113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13537,50,0.95 [0.73-1.24],0.7104092848698713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,19051,68,1.00 [0.80-1.25],0.9816143774541016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19274,291,1.04 [0.93-1.15],0.5132409751271199
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19866,193,1.01 [0.88-1.15],0.935075675114472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,20131,289,0.95 [0.85-1.06],0.3294594466244023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19794,55,1.11 [0.87-1.42],0.4088357055875915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,20187,68,0.85 [0.68-1.07],0.1656459585612198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19747,74,1.02 [0.83-1.27],0.8219058661810926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18857,237,1.01 [0.90-1.14],0.858342998213383
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19755,1135,1.03 [0.98-1.09],0.2896381452396647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,20171,396,0.94 [0.85-1.03],0.1691238453116134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19733,1782,0.98 [0.94-1.03],0.4090889584801958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19879,50,1.00 [0.77-1.29],0.9792630127908776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,20067,225,0.98 [0.87-1.11],0.7811485759907535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19722,49,1.02 [0.79-1.33],0.8781031954164435
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,20188,53,1.18 [0.91-1.51],0.2058686273109288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,19003,20,0.86 [0.57-1.31],0.4886792239019465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,19061,78,0.93 [0.76-1.15],0.5159148010521413
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Memory loss,19680,104,0.92 [0.77-1.11],0.3850827933668915
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,18783,163,1.19 [1.03-1.37],0.0179180655712901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",20185,148,1.19 [1.02-1.38],0.0250931826371268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,13642,142,1.08 [0.93-1.26],0.3340342738266405
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,20104,58,0.81 [0.64-1.03],0.0932347134813349
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19796,813,1.02 [0.95-1.09],0.581713522520569
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,19081,2971,1.00 [0.97-1.04],0.8971587708661775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19924,185,1.00 [0.87-1.14],0.9775491682749212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19293,310,1.05 [0.95-1.17],0.3551376262889345
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",20126,291,1.02 [0.92-1.14],0.6585741499654325
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15961,512,0.96 [0.89-1.04],0.3490016608591728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19736,63,0.79 [0.63-1.00],0.0531519810969357
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19798,125,0.95 [0.80-1.12],0.5086365810386901
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19883,108,0.97 [0.82-1.16],0.7672824440612176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,19068,85,0.99 [0.81-1.21],0.9362016946433516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18654,34,0.97 [0.71-1.34],0.8714491176744369
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,20105,432,0.99 [0.91-1.08],0.8183629990574993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,19206,586,1.01 [0.94-1.09],0.8099534786500111
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,20183,270,0.92 [0.82-1.03],0.1336767862001428
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19696,23,0.84 [0.57-1.23],0.3674025964335841
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,20202,36,1.05 [0.77-1.43],0.7500300784682432
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19957,533,1.00 [0.93-1.09],0.9253838774208109
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19883,48,1.09 [0.84-1.41],0.5318747383713796
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,20186,161,1.05 [0.91-1.21],0.5124097211724551
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,19009,26,1.02 [0.71-1.47],0.9085996342803166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,20203,252,0.94 [0.84-1.06],0.3014255017158531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19790,119,0.92 [0.77-1.09],0.3110935876835203
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19757,69,1.02 [0.82-1.28],0.8345192811928591
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19915,250,0.99 [0.88-1.12],0.9065053142643976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,20051,246,0.93 [0.83-1.05],0.2293115668342917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19460,38,0.87 [0.64-1.18],0.3638688443763371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19477,55,1.22 [0.96-1.56],0.1083639130938288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",20127,35,0.90 [0.66-1.23],0.5153812139551621
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,20016,103,1.13 [0.94-1.35],0.2023635235796034
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2091,58,0.96 [0.75-1.22],0.7233787517531309
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2543,107,1.03 [0.86-1.23],0.7519368463058023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19770,82,1.21 [0.99-1.48],0.0601009909094554
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,20010,840,1.03 [0.96-1.09],0.4320616939668688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19940,518,0.97 [0.90-1.06],0.519485854359367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19533,111,1.04 [0.87-1.24],0.6863317720047437
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",20141,476,1.02 [0.93-1.11],0.7000863753977546
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,20201,54,1.08 [0.85-1.39],0.523741988843202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,20087,422,1.01 [0.92-1.10],0.8198942873137447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",20170,257,1.08 [0.97-1.21],0.1743340951939009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,20126,125,1.02 [0.86-1.20],0.8346547680591462
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19487,65,1.12 [0.89-1.42],0.331085244017793
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19496,74,0.94 [0.76-1.17],0.5715521930415808
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19452,30,1.00 [0.71-1.40],0.9805333753687052
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,20125,570,1.04 [0.96-1.12],0.3638048029203143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19717,162,0.95 [0.82-1.10],0.4917603948089005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19689,24,0.82 [0.56-1.20],0.3023924956700849
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19993,80,1.04 [0.85-1.28],0.7134324716693594
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,20095,182,1.07 [0.93-1.23],0.3343732687299536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19809,144,1.05 [0.90-1.23],0.5187071967133863
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,20068,67,1.01 [0.81-1.26],0.9259594863808088
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19926,371,1.09 [0.99-1.20],0.0796538494453167
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19782,94,1.15 [0.95-1.39],0.1434875352408208
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,19067,1501,1.03 [0.98-1.08],0.2179657988862221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,20072,159,1.06 [0.92-1.23],0.4377855039608652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,20188,116,1.12 [0.95-1.33],0.1737054344636602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19782,360,0.94 [0.85-1.03],0.1865207587304861
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19970,57,1.11 [0.87-1.42],0.3790800862730535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,20191,44,1.18 [0.90-1.55],0.2396055189044742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19483,61,0.88 [0.70-1.12],0.3156802034713429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19550,128,0.85 [0.72-1.00],0.050106788927429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19274,104,1.05 [0.88-1.26],0.5912148962250414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19705,40,0.99 [0.74-1.32],0.9437154459214324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",19226,56,0.97 [0.76-1.24],0.8007736113581244
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19597,42,0.92 [0.69-1.23],0.5815426986937333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19721,166,1.09 [0.95-1.26],0.2265949653476422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19515,93,0.94 [0.77-1.14],0.521476743979258
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19276,106,1.22 [1.02-1.46],0.0256714423691231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19246,76,1.08 [0.87-1.33],0.4970713885650258
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18775,1209,1.05 [0.99-1.10],0.0864287023235543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19468,46,0.92 [0.70-1.21],0.5369380137623809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,20001,313,1.08 [0.97-1.19],0.1625210077855223
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19747,59,0.99 [0.78-1.26],0.9501614119972916
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19814,126,0.95 [0.80-1.12],0.52408285850745
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,20047,52,0.94 [0.73-1.21],0.6239045441932543
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,20169,103,1.20 [1.00-1.43],0.0501638242703145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,20087,95,1.14 [0.95-1.38],0.1647435259269001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,20041,46,1.04 [0.79-1.36],0.7828804462999837
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,20040,45,1.07 [0.81-1.40],0.6322520996176773
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,20118,787,1.06 [0.99-1.13],0.0925138130443035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19915,584,1.06 [0.98-1.14],0.1501033368972985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19441,110,0.96 [0.81-1.15],0.6773213584685494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19398,67,1.11 [0.88-1.38],0.376390582455273
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,20021,46,0.90 [0.68-1.17],0.4215850274702569
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,20130,155,0.97 [0.83-1.12],0.637380607970348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,20025,50,0.81 [0.62-1.05],0.1102260309823467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza,18318,84,1.13 [0.93-1.38],0.2254016340047842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18315,81,1.18 [0.96-1.44],0.1191949303038761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13260,87,1.04 [0.86-1.27],0.6723784108701347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,20115,234,1.04 [0.93-1.17],0.4807422376240573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14101,1219,1.01 [0.96-1.06],0.7708910110374968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14369,1196,1.01 [0.96-1.06],0.7122592653535362
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19877,123,1.08 [0.92-1.28],0.353593115830124
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18310,76,1.12 [0.91-1.38],0.2977248065805627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,17544,244,1.01 [0.90-1.14],0.8308355764466566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17335,35,1.20 [0.88-1.63],0.2463466694516637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19471,2171,1.00 [0.96-1.04],0.9945285740019648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18956,69,1.06 [0.85-1.31],0.6282031767701275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,19020,133,1.08 [0.93-1.27],0.3214256306796481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",20015,1102,0.97 [0.92-1.02],0.263905034968966
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,19013,126,0.95 [0.81-1.11],0.5088312984392446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18477,4426,1.00 [0.97-1.02],0.7977012083817497
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19229,342,0.99 [0.89-1.09],0.7919428926229466
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,19186,273,0.94 [0.84-1.05],0.2463912694530335
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Emphysema,17605,305,1.00 [0.90-1.11],0.9444828578063422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19399,304,1.04 [0.94-1.16],0.4673756869634716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19994,1760,1.01 [0.97-1.06],0.5839073806380536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,19421,326,1.07 [0.97-1.19],0.1829208237630261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,19269,829,0.98 [0.92-1.05],0.6313552664171651
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,20186,330,0.97 [0.88-1.08],0.6100943666419896
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,19015,128,0.96 [0.82-1.13],0.639969939481992
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19969,820,1.01 [0.95-1.08],0.702998647318472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19962,1847,1.03 [0.99-1.08],0.1341218040507854
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19640,753,1.00 [0.94-1.07],0.961701088326391
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,18166,51,0.98 [0.76-1.27],0.8727080645471623
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,20110,396,1.07 [0.98-1.17],0.1520812404542094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,20095,1166,1.06 [1.00-1.11],0.0474557193880178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,19051,936,1.02 [0.96-1.08],0.6015406059133221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,18345,230,0.99 [0.88-1.12],0.8940140398617096
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19778,1544,1.02 [0.97-1.06],0.5175300496218955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,20098,242,1.02 [0.90-1.15],0.7631204210316251
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,18234,119,0.90 [0.76-1.06],0.2145597619238706
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,20188,202,1.10 [0.97-1.25],0.1531091054135205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19770,56,0.96 [0.75-1.23],0.7472923158001288
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13222,49,1.23 [0.95-1.59],0.1102298548431009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19952,803,1.01 [0.95-1.08],0.7162053603217902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,19122,235,1.05 [0.93-1.18],0.4388566995908541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,18460,226,1.03 [0.91-1.16],0.6328625428505281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19895,192,0.96 [0.84-1.10],0.5955685487629984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8875,99,0.93 [0.77-1.12],0.4559809194192679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14168,73,0.99 [0.80-1.23],0.93942913340524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,20090,122,1.07 [0.90-1.26],0.4481428158137618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,15323,73,1.02 [0.82-1.26],0.891270874326319
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,19067,176,0.91 [0.80-1.05],0.2111822869480381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19891,78,0.98 [0.80-1.21],0.8660733023160176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19444,95,0.82 [0.68-0.99],0.0355368430998691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,15680,430,0.93 [0.85-1.02],0.1076807770730439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18989,98,0.97 [0.81-1.17],0.7838719635193941
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19860,98,0.97 [0.81-1.17],0.753024627853352
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,19071,180,0.93 [0.81-1.07],0.290378519295227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,19571,680,1.01 [0.94-1.08],0.7699805833457627
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,15469,219,0.86 [0.76-0.98],0.0197935862988214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18939,48,0.87 [0.67-1.14],0.3215084645624181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",20023,114,0.77 [0.65-0.92],0.0044561593703291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18821,71,1.20 [0.97-1.49],0.0929764701404467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18989,41,1.00 [0.75-1.33],0.996184912881888
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,20057,185,0.98 [0.86-1.13],0.8115626564514884
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,20065,1302,1.00 [0.95-1.06],0.8905909234552184
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,19025,77,0.91 [0.74-1.12],0.388477455639671
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19913,57,0.86 [0.68-1.10],0.2351817095625769
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,19013,65,1.04 [0.83-1.30],0.7412269426142937
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,19656,187,1.11 [0.97-1.26],0.1384523723612275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17139,1607,1.00 [0.95-1.04],0.9346938821235852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,20116,148,1.04 [0.89-1.21],0.6197926781230216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,20083,734,0.91 [0.85-0.97],0.0047446507218485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18513,3263,1.00 [0.97-1.03],0.9452409959132292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19892,423,1.06 [0.97-1.15],0.2356964193075142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,20163,350,1.00 [0.91-1.10],0.9954567258897716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19558,89,1.26 [1.04-1.52],0.0205803268867826
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19445,49,1.04 [0.80-1.35],0.7742333795882907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19937,1187,1.01 [0.96-1.07],0.608994176232047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,19455,95,1.12 [0.93-1.35],0.2392959936862315
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19904,1013,0.98 [0.93-1.04],0.5237027629806961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16675,2580,0.99 [0.95-1.02],0.4742009304246652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15468,218,0.94 [0.83-1.06],0.3230235950034845
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",20100,169,0.95 [0.83-1.10],0.4916838084804312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,20143,35,1.28 [0.94-1.73],0.114773194558705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19482,133,0.83 [0.71-0.98],0.0257793622064279
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14244,149,0.99 [0.85-1.15],0.9130949686233136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15603,353,1.01 [0.91-1.11],0.8879715258216194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,15558,308,0.98 [0.89-1.09],0.7528828808664384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,17048,1798,1.00 [0.96-1.05],0.8506905195025893
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15743,493,0.98 [0.90-1.06],0.6338737636692899
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15477,6728,0.99 [0.97-1.02],0.5206158678599425
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,19738,988,0.99 [0.94-1.05],0.8511912000392987
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19514,45,1.02 [0.78-1.35],0.8629743682199094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14886,1022,0.94 [0.89-1.00],0.0464680723042169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19420,71,0.86 [0.69-1.08],0.1901114828426997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,18474,2942,1.01 [0.97-1.04],0.7193549098383175
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,20146,34,1.30 [0.96-1.77],0.0919054817131761
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,14133,38,0.90 [0.67-1.22],0.5088677062877347
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,16912,1380,1.01 [0.96-1.06],0.7730043980800596
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15698,166,1.00 [0.86-1.15],0.9507307500957928
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14172,77,0.93 [0.75-1.14],0.4734254820755644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18834,84,1.22 [1.00-1.49],0.0449928030175639
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14334,239,0.96 [0.86-1.09],0.5524925474966447
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,20166,315,0.97 [0.87-1.07],0.5127039935639173
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19508,560,1.00 [0.93-1.08],0.9735324848912238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19691,743,0.96 [0.90-1.03],0.2655804051611803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15432,182,0.94 [0.82-1.08],0.3641454244712897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,15780,530,1.06 [0.98-1.15],0.1528604280893025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,20155,95,1.02 [0.85-1.23],0.8119971055182031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15592,60,1.05 [0.83-1.33],0.6844788640287984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15299,1204,0.99 [0.94-1.05],0.7507293191088972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,19101,210,0.97 [0.85-1.10],0.6373897149840078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18991,100,0.99 [0.83-1.19],0.9306704624014122
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,15704,1609,0.99 [0.95-1.04],0.7740626796438644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18672,4577,0.98 [0.96-1.01],0.2253847643986694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19428,152,1.10 [0.94-1.27],0.226904808396636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19936,587,0.89 [0.83-0.96],0.0030072496282763
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15852,602,0.95 [0.88-1.02],0.1565189870088036
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,19003,112,0.97 [0.81-1.15],0.7297294589090151
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,20109,296,1.01 [0.91-1.12],0.866110752145876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15915,665,0.94 [0.87-1.00],0.0672780794274324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19747,997,0.99 [0.94-1.05],0.7928318231572444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19612,143,1.04 [0.89-1.21],0.6035297597939269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15428,1333,0.99 [0.94-1.04],0.7874228027629917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16814,1564,0.97 [0.92-1.01],0.1671962350263158
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19428,79,0.79 [0.64-0.98],0.0294185488269714
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19594,646,0.98 [0.91-1.05],0.552070257495866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14391,296,1.00 [0.90-1.11],0.9665714154440672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,20134,43,1.23 [0.93-1.61],0.1430001977930338
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14498,403,0.98 [0.90-1.08],0.72871395432703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18890,140,1.06 [0.91-1.24],0.4703552907097442
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,20189,35,1.01 [0.74-1.38],0.9525534389800476
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19475,85,1.16 [0.95-1.41],0.1401184539715068
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,18988,40,0.78 [0.58-1.05],0.1024676127589346
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15508,258,0.95 [0.85-1.07],0.4284736848938878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,19073,125,0.88 [0.75-1.04],0.1390725071282917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",19052,104,0.84 [0.70-1.01],0.0647129966185898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15836,304,0.95 [0.85-1.05],0.3309143595333434
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14228,133,0.91 [0.77-1.06],0.2299847316051008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,15748,216,1.09 [0.96-1.23],0.1918013879796024
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Volvulus,14155,60,0.91 [0.71-1.15],0.4148352404810186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,20150,269,0.94 [0.84-1.05],0.2564288799785869
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19939,61,1.31 [1.04-1.65],0.0220858652360289
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18562,76,0.97 [0.79-1.20],0.7730207536289269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19579,638,0.97 [0.90-1.05],0.4583948629537326
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",19113,172,1.09 [0.95-1.25],0.2148406016809282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18856,370,0.97 [0.88-1.07],0.5386265871464403
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19955,226,1.02 [0.90-1.15],0.7726638952253926
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,20120,391,1.05 [0.96-1.15],0.3234600130634202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19768,39,1.15 [0.86-1.54],0.3576895508987229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18955,2658,1.00 [0.97-1.04],0.9933380717006408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19819,340,1.02 [0.92-1.12],0.7578245045669789
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19720,241,1.01 [0.90-1.14],0.8810418648819929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19812,871,0.99 [0.93-1.06],0.8287895376846194
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",20193,24,1.16 [0.80-1.68],0.4319575263369833
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18509,23,1.30 [0.89-1.90],0.1815938450584411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19532,53,1.09 [0.85-1.41],0.4844334298486614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19951,222,1.01 [0.90-1.15],0.8258656428829463
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18889,403,1.01 [0.92-1.10],0.8635526271358708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18551,65,0.95 [0.76-1.19],0.6561330988417355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,20147,69,1.13 [0.91-1.41],0.2800883253463872
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,19110,169,1.06 [0.92-1.22],0.4108092775844136
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,20058,180,1.06 [0.93-1.22],0.3759664502414993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19786,57,0.95 [0.75-1.22],0.7131039415817771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18538,52,0.94 [0.73-1.22],0.6545616588706746
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19823,1337,0.99 [0.94-1.04],0.6259944647979478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18925,439,1.02 [0.93-1.11],0.6989472779001871
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18554,68,0.97 [0.77-1.21],0.7591395909203832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,20128,250,1.14 [1.01-1.27],0.0304426360548757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19775,46,1.38 [1.05-1.80],0.0197724103944694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,20098,220,1.14 [1.01-1.29],0.034109741947228
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,20166,285,0.94 [0.84-1.04],0.2352480539082153
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18558,72,1.01 [0.81-1.25],0.9402219178605932
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18710,224,0.87 [0.77-0.99],0.0303365463222103
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,20160,279,0.93 [0.83-1.04],0.2110225531151268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18693,207,1.02 [0.90-1.16],0.7668336798500051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,20181,103,1.11 [0.92-1.33],0.2668332968348997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17433,69,0.92 [0.74-1.15],0.4668573618683833
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18425,4012,1.02 [0.99-1.05],0.2056417321005607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17237,2824,1.02 [0.98-1.05],0.3947623485031439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17427,63,1.00 [0.79-1.26],0.9997937329800524
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17771,121,1.00 [0.84-1.18],0.9548293631645433
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17770,120,0.99 [0.84-1.17],0.9081471592702112
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,20027,55,1.02 [0.80-1.30],0.8978204677526277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17715,65,0.86 [0.69-1.08],0.2048733588735281
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15140,727,1.04 [0.97-1.12],0.2372022225957142
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",20101,123,0.98 [0.83-1.16],0.8224597098924931
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17871,221,1.07 [0.94-1.21],0.3064319452211023
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17189,5257,1.01 [0.99-1.04],0.2559323477991526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19322,81,0.88 [0.72-1.08],0.2183942017684738
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17503,139,0.90 [0.77-1.05],0.1844406422219519
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17746,382,1.03 [0.94-1.13],0.5186472454666451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19494,1844,1.01 [0.97-1.05],0.7373417360866957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17681,317,0.98 [0.89-1.09],0.747540032237581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17407,43,1.26 [0.96-1.66],0.1001966539414283
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17449,85,0.97 [0.80-1.19],0.7718695168608245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19926,26,1.07 [0.75-1.55],0.7002306202796132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15626,1213,1.01 [0.96-1.07],0.6761910426830835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15218,805,1.02 [0.96-1.09],0.4891961285905684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",20081,792,1.03 [0.96-1.10],0.3748274540668016
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14450,37,0.85 [0.63-1.15],0.2976899687089867
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14479,66,0.94 [0.75-1.17],0.5708660093396681
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17587,223,1.05 [0.93-1.18],0.4730464380734224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14944,531,1.05 [0.97-1.13],0.2704291821742384
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17682,32,1.24 [0.90-1.71],0.1857025124632066
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,18087,437,0.99 [0.90-1.08],0.7553538128573064
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17866,216,1.02 [0.90-1.15],0.7720814893047145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14909,496,1.02 [0.94-1.11],0.6061579895396085
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17420,56,1.15 [0.90-1.47],0.2616146206455907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17406,42,1.15 [0.87-1.52],0.3194222422849225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19317,76,0.99 [0.80-1.22],0.9276301246587664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19958,717,0.94 [0.87-1.00],0.0601446577870695
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19571,330,0.91 [0.82-1.01],0.0725928144540293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",20137,250,1.03 [0.91-1.15],0.6514921791164641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15992,1579,1.04 [0.99-1.09],0.1147175387298375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14459,46,0.91 [0.70-1.20],0.5066825795344485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17430,66,1.02 [0.81-1.27],0.8798356473586637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14460,47,0.86 [0.65-1.13],0.2717917188732685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14451,38,0.95 [0.70-1.27],0.7119347737607952
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19396,155,0.97 [0.83-1.12],0.6437094987914467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19377,136,0.95 [0.81-1.11],0.5402209166231229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,20175,71,1.12 [0.90-1.39],0.3091738609315902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18914,1264,1.01 [0.96-1.06],0.7873869991629312
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17420,56,1.21 [0.95-1.54],0.1188912719454441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14447,34,1.07 [0.78-1.47],0.6897919502232065
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,18167,517,1.02 [0.94-1.11],0.624210650839589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15848,1435,1.04 [0.99-1.09],0.1344719011332152
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19945,45,1.21 [0.92-1.60],0.1629648584421981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,20190,55,1.31 [1.03-1.68],0.0286276848215499
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17436,72,1.07 [0.86-1.33],0.5686256372694691
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",18177,813,1.06 [1.00-1.14],0.055686025838435
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17442,78,0.90 [0.73-1.11],0.3120831969210659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15434,1021,1.04 [0.98-1.10],0.2008829416178468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19311,70,0.92 [0.74-1.15],0.4628349489129777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17402,38,1.23 [0.91-1.65],0.1751419344495318
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17743,93,0.95 [0.78-1.15],0.5667043594655699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17777,413,0.99 [0.91-1.09],0.8727553572163027
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,20064,164,1.02 [0.88-1.18],0.7771642452044049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,18050,400,0.99 [0.91-1.09],0.8696816961859359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,20145,247,1.01 [0.90-1.14],0.8257296244874399
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,20191,31,1.23 [0.88-1.70],0.2243082277415166
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17491,127,0.95 [0.81-1.12],0.5746073015229902
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16596,478,1.07 [0.99-1.17],0.0949763237275302
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17758,394,1.05 [0.96-1.16],0.2574328420783232
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17651,287,0.96 [0.86-1.07],0.5062524792295737
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14438,25,1.00 [0.69-1.44],0.9870675039216588
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16314,1901,1.03 [0.99-1.08],0.1385651502792622
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14783,370,0.94 [0.85-1.03],0.1923633049883531
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,20036,136,0.99 [0.85-1.16],0.927103847799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",20141,37,1.04 [0.77-1.41],0.8082657235923599
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18540,37,1.27 [0.94-1.72],0.1213147997287056
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14470,57,1.33 [1.05-1.69],0.0196111536642535
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17726,76,1.10 [0.89-1.36],0.360941509231607
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14670,257,1.04 [0.92-1.16],0.5431204916279466
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17609,245,1.10 [0.98-1.24],0.0986506097251659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17830,180,1.11 [0.97-1.27],0.1390192674600646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17720,70,0.98 [0.78-1.22],0.830066325013014
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,16071,26,1.13 [0.79-1.62],0.5103316688517614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",20192,32,1.26 [0.91-1.73],0.1637886640824397
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17809,445,1.04 [0.95-1.13],0.3975087323207209
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19917,17,1.14 [0.74-1.78],0.5519086606919117
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19284,1920,1.02 [0.98-1.07],0.3022940059699873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17452,88,1.19 [0.98-1.45],0.0783443096605481
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,18058,408,1.02 [0.93-1.12],0.655890354565372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19294,165,1.02 [0.89-1.18],0.7520284449065813
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17768,118,1.09 [0.92-1.29],0.3101993912762467
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18735,1085,1.03 [0.97-1.09],0.2881973539557939
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18325,675,1.05 [0.97-1.12],0.2230115536866133
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17397,33,1.08 [0.78-1.48],0.6535489471628473
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19937,37,1.22 [0.90-1.65],0.1917640820498459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17472,108,1.24 [1.04-1.48],0.0152679829657518
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17382,18,1.09 [0.70-1.70],0.6887484970309077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14464,51,1.04 [0.80-1.34],0.7873356270312939
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19464,1513,0.99 [0.94-1.03],0.5887886015478592
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19806,340,0.96 [0.87-1.06],0.4428048745934675
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19587,121,0.93 [0.78-1.10],0.3826964611410509
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19073,1122,0.94 [0.89-0.99],0.0182956931950525
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,20007,50,0.77 [0.59-1.00],0.0508969572589758
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,20003,290,0.94 [0.85-1.05],0.3023166445162586
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,17825,171,1.01 [0.88-1.17],0.8380498053597547
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,18017,66,1.08 [0.86-1.35],0.5214198348218981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,19134,2794,1.03 [0.99-1.06],0.1200043014813911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18262,4674,1.00 [0.97-1.02],0.7805321917569358
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,20030,73,1.10 [0.89-1.36],0.3913851130960519
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16515,175,1.10 [0.96-1.27],0.1667893860211637
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,18022,288,1.07 [0.96-1.20],0.1942985141090294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18537,2197,1.02 [0.98-1.06],0.3274373472597727
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16535,195,0.90 [0.79-1.03],0.1249306377085785
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17717,63,0.97 [0.76-1.22],0.7651717902340945
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16436,96,0.93 [0.77-1.12],0.4403563886282997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",20196,51,0.95 [0.73-1.23],0.6840925043069079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",20196,43,0.82 [0.62-1.09],0.1667395040782348
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19505,1851,0.98 [0.94-1.02],0.3135554493029153
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18459,805,0.96 [0.90-1.03],0.2791709143887061
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,20145,432,0.96 [0.88-1.05],0.3616303382499563
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16600,260,1.01 [0.90-1.13],0.900793597150343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16574,234,0.99 [0.87-1.11],0.8091899164088381
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16535,195,1.06 [0.93-1.21],0.3899767932470631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,20192,41,0.94 [0.71-1.26],0.6885974654822635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18896,1242,0.99 [0.94-1.04],0.6458639277755609
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,18055,321,1.06 [0.96-1.18],0.2509309351119701
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19854,141,0.93 [0.79-1.08],0.3388025629810597
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,20009,52,0.82 [0.63-1.06],0.136296070665514
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16562,222,1.01 [0.89-1.14],0.924254091116478
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19991,2257,0.98 [0.94-1.02],0.2869516181240786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17787,53,0.91 [0.71-1.17],0.4676712474645559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,18066,115,0.98 [0.82-1.16],0.774143836709472
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19528,62,1.15 [0.91-1.45],0.2316789225812895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17906,252,0.99 [0.88-1.11],0.8046952270137404
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19909,443,0.95 [0.87-1.04],0.2557499063800018
